There's been a scientific breakthrough in the war on terrorism.
Hollis-Eden Pharmaceuticals based in San Diego, California, has created what could be the antidote to a radiation attack. The hormone based drug is called Neumune.
Hollis-Eden has conducted clinical trials on rhesus monkeys. All of the primates were exposed to lethal doses of radiation but, after being treated with Neumune, most survived.